- Report
- May 2024
- 90 Pages
United States
From €5297EUR$5,950USD£4,628GBP
- Report
- February 2024
- 130 Pages
Global
From €5297EUR$5,950USD£4,628GBP
- Report
- October 2023
- 120 Pages
Global
From €5297EUR$5,950USD£4,628GBP
- Report
- July 2023
- 150 Pages
Global
From €5297EUR$5,950USD£4,628GBP
- Report
- September 2024
- 200 Pages
Global
From €2226EUR$2,500USD£1,945GBP
- Report
- August 2024
- 208 Pages
Global
From €2226EUR$2,500USD£1,945GBP
- Report
- April 2024
- 169 Pages
Global
From €2226EUR$2,500USD£1,945GBP
- Report
- July 2022
- 120 Pages
Global
From €2226EUR$2,500USD£1,945GBP
- Report
- September 2024
- 253 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- February 2025
- 85 Pages
India
From €3116EUR$3,500USD£2,722GBP
- Report
- October 2024
- 134 Pages
North America
From €3561EUR$4,000USD£3,111GBP
- Report
- August 2024
- 187 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- July 2024
- 181 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- July 2024
- 182 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- May 2024
- 182 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- May 2024
- 182 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- April 2023
- 80 Pages
Germany
From €4228EUR$4,750USD£3,695GBP
- Report
- January 2022
- 112 Pages
Global
From €4228EUR$4,750USD£3,695GBP
- Report
- February 2024
- 104 Pages
Europe
From €2626EUR$2,950USD£2,295GBP
- Report
- November 2023
- 101 Pages
Asia Pacific
From €1091EUR$1,225USD£953GBP
€2181EUR$2,450USD£1,906GBP

The oligonucleotide market is a subset of the biotechnology industry that focuses on the production and sale of oligonucleotides, which are short strands of nucleic acids used in a variety of applications. Oligonucleotides are used in research, diagnostics, and therapeutics, and are essential components of many biotechnological processes. They are used in a variety of applications, including gene expression analysis, gene cloning, and gene sequencing.
The oligonucleotide market is expected to grow in the coming years due to increasing demand for biotechnological products and services. The market is driven by advances in technology, such as the development of new sequencing techniques, and the increasing use of oligonucleotides in drug discovery and development.
Some of the major companies in the oligonucleotide market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck KGaA, and Qiagen. These companies are involved in the production and sale of oligonucleotides, as well as the development of new technologies and products. Show Less Read more